GSK-29060/03/001

Study Sponsor: GSK

Study Title

A Double-Blind, Imipramine- and Placebo-Controlled Study of Paroxetine in Depressed Outpatients

Medicine or Vaccine (generic name)

paroxetine

Sponsor Identification Number

29060/03/001

Trial Registry Identification Number(#'s)

Medical Condition

Depressive Disorder

Phase

Phase 3

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=29060/03/001

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study has multiple results summaries on the GSK Study Register under the following clinical study identifiers: PAR 03 001, PAR 29060/03/002, PAR 29060.03.003, PAR 29060.03.004, PAR 29060.03.005, PAR 29060.03.006, and PAR03_001. This posting links only to PAR 03 001. All other results summaries must be viewed directly from the GSK Study Register. An analysis-ready dataset is not available for this study. An annotated case report form and a reporting and analysis plan are not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.

Date Added to this Site

May 2014